PetroVietnam General Services JSC (HOSE:PET)

CTI BioPharma Income Statement

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	18,991,217	19,043,708	17,217,791	17,543,323	17,598,238	13,453,249
Revenue Growth (YoY)	10.18%	10.61%	-1.86%	-0.31%	30.81%	34.42%
Cost of Revenue	18,098,844	18,153,816	16,495,455	16,576,219	16,659,038	12,784,349
Gross Profit	892,373	889,892	722,337	967,104	939,199	668,900
Selling, General & Admin	658,477	615,158	530,184	483,025	556,317	434,354
Operating Expenses	658,477	615,158	530,184	483,025	556,317	434,354
Operating Income	233,896	274,734	192,153	484,079	382,882	234,546
Interest Expense	-195,699	-143,846	-309,588	-139,993	-81,065	-76,420
Interest & Investment Income	186,139	140,351	274,660	100,560	41,069	26,290
Earnings From Equity Investments	-6,230	-11,153	-3,359	-5,661	-605.72	-700
Currency Exchange Gain (Loss)	34,003	14,440	12,329	-	14,001	6,627
Other Non Operating Income (Expenses)	15,855	7,401	16,234	-19,772	25,435	12,268
EBT Excluding Unusual Items	267,964	281,928	182,430	419,214	381,716	202,611
Gain (Loss) on Sale of Investments	35,481	-	-	-206,119	33,624	427.08
Gain (Loss) on Sale of Assets	1,322	1,322	-	-	-	3,905
Pretax Income	304,767	283,250	182,430	213,096	415,340	206,943
Income Tax Expense	69,667	63,372	43,433	45,677	103,881	66,776
Earnings From Continuing Operations	235,100	219,877	138,997	167,418	311,459	140,167
Minority Interest in Earnings	-69,071	-70,215	-27,572	-56,988	-46,615	-2,915
Net Income	166,029	149,662	111,425	110,430	264,844	137,252
Preferred Dividends & Other Adjustments	10,471	7,795	6,734	5,483	13,843	9,063
Net Income to Common	155,558	141,867	104,691	104,947	251,001	128,189
Net Income Growth	18.05%	34.32%	0.90%	-58.30%	92.96%	12.44%
Shares Outstanding (Basic)	107	107	107	107	102	99
Shares Outstanding (Diluted)	107	107	107	107	102	99
Shares Change (YoY)	-0.03%	-	-	4.96%	2.41%	-1.69%
EPS (Basic)	1457.60	1329.31	980.97	983.37	2468.67	1291.16
EPS (Diluted)	1457.29	1329.00	980.97	983.00	2468.67	1291.16
EPS Growth	18.03%	35.48%	-0.21%	-60.18%	91.20%	16.12%
Free Cash Flow	725,384	363,716	-325,462	-207,937	64,262	-56,580
Free Cash Flow Per Share	6796.94	3408.07	-3049.62	-1948.40	632.03	-569.90
Dividend Per Share	-	-	-	-	-	841.751
Gross Margin	4.70%	4.67%	4.20%	5.51%	5.34%	4.97%
Operating Margin	1.23%	1.44%	1.12%	2.76%	2.18%	1.74%
Profit Margin	0.82%	0.74%	0.61%	0.60%	1.43%	0.95%
Free Cash Flow Margin	3.82%	1.91%	-1.89%	-1.19%	0.36%	-0.42%
EBITDA	297,289	347,160	261,182	550,572	445,195	298,782
EBITDA Margin	1.57%	1.82%	1.52%	3.14%	2.53%	2.22%
D&A For EBITDA	63,393	72,426	69,029	66,492	62,312	64,236
EBIT	233,896	274,734	192,153	484,079	382,882	234,546
EBIT Margin	1.23%	1.44%	1.12%	2.76%	2.18%	1.74%
Effective Tax Rate	22.86%	22.37%	23.81%	21.44%	25.01%	32.27%
Revenue as Reported	18,991,217	19,043,708	17,217,791	17,543,323	17,598,238	13,453,249
Advertising Expenses	-	-	-	-	30,248	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.